Literature DB >> 23423609

Amadori glycated proteins: role in production of autoantibodies in diabetes mellitus and effect of inhibitors on non-enzymatic glycation.

Nadeem A Ansari1, Debabrata Dash.   

Abstract

Nonenzymatic glycation of macromolecules, especially proteins leading to their oxidation is increased in diabetes mellitus due to hyperglycemia and play an important role in associated complications of the disease. The glycation primarily occurs at intrachain lysine residues of proteins and results in the formation of an early stage stable product as Amadori-lysine which undergo further irreversible chemical reactions to form advanced glycation endproducts. This review deals with the role of Amadori modified proteins in pathogenesis of diabetes. We aim to explain immunogenicity of Amadori-glycated proteins, which might be involve in production of serum autoantibodies in the diabetic patients, and effect of inhibitors on the glycation process.

Entities:  

Keywords:  Amadori products; Antibodies; diabetes complications; lysine rich proteins

Year:  2012        PMID: 23423609      PMCID: PMC3570141     

Source DB:  PubMed          Journal:  Aging Dis        ISSN: 2152-5250            Impact factor:   6.745


  44 in total

Review 1.  Advanced glycation end-products: a review.

Authors:  R Singh; A Barden; T Mori; L Beilin
Journal:  Diabetologia       Date:  2001-02       Impact factor: 10.122

2.  The in vitro inhibition effect of 2 nm gold nanoparticles on non-enzymatic glycation of human serum albumin.

Authors:  Champika Seneviratne; Radha Narayanan; W Liu; J A Dain
Journal:  Biochem Biophys Res Commun       Date:  2012-05-10       Impact factor: 3.575

3.  Inhibition of nonenzymatic protein glycation and lipid peroxidation by drugs with antioxidant activity.

Authors:  V Jakus; M Hrnciarová; J Cársky; B Krahulec; N Rietbrock
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

4.  Amadori rearrangement of glyceraldehyde-hemoglobin Schiff base adducts. A new procedure for the determination of ketoamine adducts in proteins.

Authors:  A S Acharya; J M Manning
Journal:  J Biol Chem       Date:  1980-08-10       Impact factor: 5.157

5.  Non-enzymatic glycosylation of immunoglobulins in diabetic nephropathy.

Authors:  Kiran Kalia; Seema Sharma; Kinnari Mistry
Journal:  Clin Chim Acta       Date:  2004-09       Impact factor: 3.786

Review 6.  Peptide and amino acid glycation: new insights into the Maillard reaction.

Authors:  Stefica Horvat; Andreja Jakas
Journal:  J Pept Sci       Date:  2004-03       Impact factor: 1.905

7.  Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry.

Authors:  Paul J Thornalley; Sinan Battah; Naila Ahmed; Nikolaos Karachalias; Stamatina Agalou; Roya Babaei-Jadidi; Anne Dawnay
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

8.  Glycation of amino groups in protein. Studies on the specificity of modification of RNase by glucose.

Authors:  N G Watkins; S R Thorpe; J W Baynes
Journal:  J Biol Chem       Date:  1985-09-05       Impact factor: 5.157

9.  Inhibition of glycation reaction in tissue protein incubations by water soluble rutin derivative.

Authors:  Takashi Nagasawa; Nobuaki Tabata; Yoshiaki Ito; Naoyuki Nishizawa; Youichi Aiba; David D Kitts
Journal:  Mol Cell Biochem       Date:  2003-07       Impact factor: 3.396

10.  Amadori-albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients.

Authors:  C G Schalkwijk; N Chaturvedi; H Twaafhoven; V W M van Hinsbergh; C D A Stehouwer
Journal:  Eur J Clin Invest       Date:  2002-07       Impact factor: 4.686

View more
  14 in total

1.  Structural stability of myoglobin and glycomyoglobin: a comparative molecular dynamics simulation study.

Authors:  Joulia Alizadeh-Rahrovi; Alireza Shayesteh; Azadeh Ebrahim-Habibi
Journal:  J Biol Phys       Date:  2015-02-21       Impact factor: 1.365

Review 2.  An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus.

Authors:  Km Neelofar; Jamal Ahmad
Journal:  Glycoconj J       Date:  2017-08-15       Impact factor: 2.916

Review 3.  AGE/Non-AGE Glycation: An Important Event in Rheumatoid Arthritis Pathophysiology.

Authors:  Prachi Agnihotri; Sagarika Biswas
Journal:  Inflammation       Date:  2021-11-17       Impact factor: 4.092

Review 4.  Translating the advanced glycation end products (AGEs) knowledge into real-world nutrition strategies.

Authors:  Heitor O Santos; Nilson Penha-Silva
Journal:  Eur J Clin Nutr       Date:  2021-10-21       Impact factor: 4.884

5.  Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.

Authors:  Sidar Copur; Dimitrie Siriopol; Baris Afsar; Melis C Comert; Gizem Uzunkopru; Alan A Sag; Alberto Ortiz; Adrian Covic; Daniel H van Raalte; David Z Cherney; Peter Rossing; Mehmet Kanbay
Journal:  Acta Diabetol       Date:  2020-08-30       Impact factor: 4.280

6.  The role of acetoacetate in Amadori product formation of human serum albumin.

Authors:  Mousa Bohlooli; Mansour Ghaffari-Moghaddam; Mostafa Khajeh; Gholamreza Shahraki-Fallah; Batool Haghighi-Kekhaiye; Nader Sheibani
Journal:  J Photochem Photobiol B       Date:  2016-09-06       Impact factor: 6.252

Review 7.  Amadori albumin in diabetic nephropathy.

Authors:  Km Neelofar; Jamal Ahmad
Journal:  Indian J Endocrinol Metab       Date:  2015 Jan-Feb

8.  Non-enzymatic glucosylation induced neo-epitopes on human serum albumin: A concentration based study.

Authors:  Km Neelofar; Zarina Arif; Jamal Ahmad; Khursheed Alam
Journal:  PLoS One       Date:  2017-02-13       Impact factor: 3.240

9.  Assessment of the Anti-Hyperglycaemic, Anti-Inflammatory and Antioxidant Activities of the Methanol Extract of Moringa Oleifera in Diabetes-Induced Nephrotoxic Male Wistar Rats.

Authors:  Elizabeth I Omodanisi; Yapo G Aboua; Oluwafemi O Oguntibeju
Journal:  Molecules       Date:  2017-03-23       Impact factor: 4.411

10.  Commercial processed soy-based food product contains glycated and glycoxidated lunasin proteoforms.

Authors:  Aida Serra; Xavier Gallart-Palau; Rachel Su-En See-Toh; Xinya Hemu; James P Tam; Siu Kwan Sze
Journal:  Sci Rep       Date:  2016-05-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.